CNCR Summary


The Loncar Cancer Immunotherapy ETF

ETF Information as of 01/19/2018

ETF Summary

ETF Info
Primary Exchange NASDAQ
Ticker CNCR
Index Symbol LCINDX
Index Provider Loncar Investments, LLC
Index Calculator Indxx, LLC
CUSIP 26922A826
Net Assets $43,780,964.48
Shares Outstanding 1,650,000
Number of Holdings 31
Weighting Equal-Weighted
Rebalanced Semi-Annually
Reconstituted Semi-Annually
Fund Inception Date 10/13/15
Management Fee 0.79%
Gross Expense Ratio 0.79%
Net Asset Value $26.53
Daily Change
Market Price
Closing Price $26.56
Daily Change $0.50
Premium Discount
NAV $26.53
Mid-Point $26.56
Premium/Discount 0.10%
Ex-Date 12/28/2017
Record Date 12/29/2017
Payable Date 1/2/2018
Amount $0.35019938
Short-Term Capital Gains N/A

The fund's investment in securities that are less actively traded or over time experience decreased trading volume may affect adversely the fund's ability to make dividend distributions.

Download Investor Materials